IFP Advisors Inc Raises Stake in iShares Biotechnology ETF (NASDAQ:IBB)

IFP Advisors Inc lifted its position in shares of iShares Biotechnology ETF (NASDAQ:IBB) by 237.1% in the fourth quarter, according to its most recent 13F filing with the SEC. The firm owned 16,018 shares of the financial services provider’s stock after purchasing an additional 11,266 shares during the quarter. IFP Advisors Inc’s holdings in iShares Biotechnology ETF were worth $2,118,000 as of its most recent filing with the SEC.

A number of other institutional investors have also modified their holdings of IBB. BNP Paribas Financial Markets grew its holdings in shares of iShares Biotechnology ETF by 29.3% during the 3rd quarter. BNP Paribas Financial Markets now owns 2,380,229 shares of the financial services provider’s stock worth $346,561,000 after purchasing an additional 538,899 shares during the period. Healthcare of Ontario Pension Plan Trust Fund grew its holdings in shares of iShares Biotechnology ETF by 32.9% during the 3rd quarter. Healthcare of Ontario Pension Plan Trust Fund now owns 663,000 shares of the financial services provider’s stock worth $96,533,000 after purchasing an additional 164,000 shares during the period. Aprio Wealth Management LLC purchased a new stake in shares of iShares Biotechnology ETF during the 4th quarter worth about $18,476,000. DRW Securities LLC purchased a new stake in shares of iShares Biotechnology ETF during the 3rd quarter worth about $5,990,000. Finally, Erste Asset Management GmbH purchased a new position in iShares Biotechnology ETF in the 3rd quarter worth approximately $5,678,000. Hedge funds and other institutional investors own 62.45% of the company’s stock.

iShares Biotechnology ETF Stock Performance

NASDAQ IBB opened at $137.86 on Wednesday. iShares Biotechnology ETF has a fifty-two week low of $123.60 and a fifty-two week high of $150.57. The business has a 50 day moving average price of $135.64 and a two-hundred day moving average price of $140.74.

iShares Biotechnology ETF Cuts Dividend

The business also recently declared a dividend, which was paid on Friday, December 20th. Shareholders of record on Tuesday, December 17th were issued a $0.0624 dividend. The ex-dividend date of this dividend was Tuesday, December 17th.

iShares Biotechnology ETF Company Profile

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.